Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications
CDK4/6 inhibitors promote PARP1 degradation and act synergistically with PARP inhibitors in non-small cell lung cancer.
Journal: bioRxiv : the preprint server for biology
Published: July 19, 2024
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer.
Journal: Translational oncology
Published: June 24, 2024
Oligo-benzamide-based peptide mimicking tools for modulating biology.
Journal: Methods in enzymology
Published: June 17, 2024
Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress.
Journal: Nature cancer
Published: May 20, 2024
ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers.
Journal: bioRxiv : the preprint server for biology
Published: November 14, 2023
Evaluating physiochemical properties of FDA-approved orally administered drugs.
Journal: Expert opinion on drug discovery
Published: November 03, 2023
Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer.
Journal: Cancer discovery
Published: March 21, 2023
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.
Journal: Journal of the Endocrine Society
Published: February 07, 2023
Last Updated: 09/26/2026